Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
IE |
|
G
|
Good Flour Corp
CNSX:GFCO
|
CA |
|
Global Education Communities Corp
TSX:GEC
|
CA |
|
A
|
Atlan Holdings Bhd
KLSE:ATLAN
|
MY |
|
T
|
Turbon AG
F:TUR
|
DE |
|
R
|
Roctec Global PCL
SET:ROCTEC
|
TH |
Wall Street
Price Targets
JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
JAZZ
is 228.13 USD
with a low forecast of 189.88 USD and a high forecast of 288.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JAZZ's stock price target?
Price Target
228.13
USD
According to Wall Street analysts, the average 1-year price target for
JAZZ
is 228.13 USD
with a low forecast of 189.88 USD and a high forecast of 288.75 USD.
What is Jazz Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Jazz Pharmaceuticals PLC's revenue is
22%.
The projected
CAGR
for the next 3 years is
7%.
What is Jazz Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
62%
For the last 14 years the
compound annual growth rate for
Jazz Pharmaceuticals PLC's operating income is
11%.
The projected
CAGR
for the next 3 years is
62%.
